Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
2250830
Reference Type
Journal Article
Title
Visual compatibility of ranitidine hydrochloride with commonly used critical care medications
Author(s)
Chilvers, MR; Lysne, JM
Year
1989
Is Peer Reviewed?
Yes
Journal
American Journal of Hospital Pharmacy
ISSN:
0002-9289
Report Number
IPA/90/876678
Volume
J
Issue
REF 3
Page Numbers
2057-2058
Language
eng
Abstract
IPA COPYRIGHT: ASHP The visual compatibility of ranitidine hydrochloride (I) injection with commonly used critical-care medications was studied under conditions simulating Y-site administration; one ml of I was mixed in glass vials with one ml of each secondary additive being tested. Drugs tested for compatibility with I included cardiac drugs (bretylium tosylate, procainamide hydrochloride), sympathomimetic agents (dobutamine hydrochloride, dopamine hydrochloride), aminophylline, heparin sodium and nitroglycerin. Samples drawn up in disposable plastic syringes were examined at 30 min and 1, 2, 4, 8, and 24 h after preparation for turbidity, haze, precipitation, gas production, color changes, and other signs of visual incompatibility. No visible signs of incompatibility were noted during the 24 h study period in any of drug combinations investigated. At concentrations tested, I appeared to be visually compatible with other injectable drugs commonly administered to critically ill patients.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity